Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE880.4510.1 (+1.16 %)

PREV CLOSE ( ) 870.35

OPEN PRICE ( ) 894.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1304

TODAY'S LOW / HIGH ( )865.30 894.80

52 WK LOW / HIGH ( ) 6501249

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-06 1987

Management Info

Daulat N Medhora - Chairman Fredun N Medhora - Managing Director

Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (W),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE

NEWS

22Mar Allotment of Convertible warrants
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..

22Mar Allotment of Equity Shares
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..

12Feb Fredun Pharmaceuticals gets orders wor
Fredun Pharmaceuticals has received large orders from Southeast Asian (S..

12Feb Fredun Pharmaceuticals informs about p
Fredun Pharmaceuticals has informed that it enclosed press release title..

19Jan Fredun Pharmaceuticals informs about v
Fredun Pharmaceuticals has informed that it enclosed the Voting Results..

Financials

Rs. in Millions

	QTR Mar 24	ANNUAL 24
Net Profit	50.6300000000001	156.24
Gross Profit	58.3900000000001	214.52
Operating Profit	111.67	388.98
Net Sales	1180.33	3490.72

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26643.70 (0.58%)	M.Cap ( in Cr)56616.00
Pfizer (BSE) 4473.85 (1.59%)	M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE) 2355.75 (2.80%)	M.Cap ( in Cr)39907.83
Concord Biotech (BSE) 1494.85 (4.43%)	M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE) 1104.45 (5.00%)	M.Cap ( in Cr)111133.51

Shareholding Pattern

	NON-INSTITUTION	49.28%
	PROMOTERS	49.13%
	FI/BANKS/INSURANCE	1.6%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

FREDUN PHARMACEUTICALS LTD.